Suchergebnisse - "Rubin, David T"

PubPharm (34)

21

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2017

von Feagan, B. | Rubin, D. | Danese, S. | +5

22

Safety and Efficacy of Live Measles Vaccine Administered to a Crohn's Disease Patient Receiving Vedolizumab

enthalten in: The American journal of gastroenterology | 2016

von Wichmann, A. | Krugliak Cleveland, N. | Rubin, D.

23

Vedolizumab in the treatment of Crohn's disease

enthalten in: Expert review of gastroenterology & hepatology | 2016

von Tarabar, D. | Hirsch, A. | Rubin, D.

24

Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease

enthalten in: Inflammatory bowel diseases | 2014

von Stein, A. | Rubin, D. | Hanauer, S. | +1

25

Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease

enthalten in: Inflammatory bowel diseases | 2013

von Sakuraba, A. | Annunziata, M. | Cohen, R. | +2

26

Serum adalimumab concentration and clinical remission in patients with Crohn's disease

enthalten in: Inflammatory bowel diseases | 2013

von Chiu, Y. | Rubin, D. | Vermeire, S. | +5

27

Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2013

von Mahadevan, U. | Wolf, D. | Dubinsky, M. | +9

CommentIn: Clin Gastroenterol Hepatol. 2013 Mar;11(3):293-4. - PMID 23247325

28

Natalizumab in Crohn's disease : results from a US tertiary inflammatory bowel disease center

enthalten in: Inflammatory bowel diseases | 2013

von Sakuraba, A. | Keyashian, K. | Correia, C. | +4

29

Response to biologic therapy in Crohn's disease is improved with early treatment : an analysis of health claims data

enthalten in: Inflammatory bowel diseases | 2012

von Rubin, D. | Uluscu, O. | Sederman, R.

30

Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease : results from the CHARM trial

enthalten in: Inflammatory bowel diseases | 2012

von Rubin, D. | Mulani, P. | Chao, J. | +4